These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9526571)

  • 21. Synthesis and Evaluation of 2-Azetidinone and 1H-Pyrrole-2,5-dione Derivatives as Cholesterol Absorption Inhibitors for Reducing Inflammation Response and Oxidative Stress.
    Xia Y; Zhu L; Yuan X; Wang Y
    Chem Biodivers; 2019 Feb; 16(2):e1800189. PubMed ID: 30230227
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disposition of the selective cholesterol absorption inhibitor ezetimibe in healthy male subjects.
    Patrick JE; Kosoglou T; Stauber KL; Alton KB; Maxwell SE; Zhu Y; Statkevich P; Iannucci R; Chowdhury S; Affrime M; Cayen MN
    Drug Metab Dispos; 2002 Apr; 30(4):430-7. PubMed ID: 11901097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and bioactivities of 2-azetidinone derivatives as cholesterol absorption inhibitors.
    Wang Y; Qian H; Zhou J; Zhang H; Ji J; Huang W
    Med Chem; 2011 Nov; 7(6):534-42. PubMed ID: 22313293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Substituted 2-azaspiro[5.3]nonan-1-ones as potent cholesterol absorption inhibitors: defining a binding conformation for SCH 48461.
    Dugar S; Clader JW; Chan TM; Davis H
    J Med Chem; 1995 Dec; 38(25):4875-7. PubMed ID: 8523398
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of melatonin on cholesterol absorption in rats.
    Hussain SA
    J Pineal Res; 2007 Apr; 42(3):267-71. PubMed ID: 17349025
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of 2-azetidinone and 1H-pyrrole-2,5-dione derivatives containing sulfonamide group at the side chain as potential cholesterol absorption inhibitors.
    Yuan X; Lu P; Xue X; Qin H; Fan C; Wang Y; Zhang Q
    Bioorg Med Chem Lett; 2016 Feb; 26(3):849-853. PubMed ID: 26783178
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of potent, nonsystemic apical sodium-codependent bile acid transporter inhibitors (Part 1).
    Tremont SJ; Lee LF; Huang HC; Keller BT; Banerjee SC; Both SR; Carpenter AJ; Wang CC; Garland DJ; Huang W; Jones C; Koeller KJ; Kolodziej SA; Li J; Manning RE; Mahoney MW; Miller RE; Mischke DA; Rath NP; Fletcher T; Reinhard EJ; Tollefson MB; Vernier WF; Wagner GM; Rapp SR; Beaudry J; Glenn K; Regina K; Schuh JR; Smith ME; Trivedi JS; Reitz DB
    J Med Chem; 2005 Sep; 48(18):5837-52. PubMed ID: 16134950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis of a biotin-tagged photoaffinity probe of 2-azetidinone cholesterol absorption inhibitors.
    Frick W; Bauer-Schäfer A; Bauer J; Girbig F; Corsiero D; Heuer H; Kramer W
    Bioorg Med Chem; 2003 Apr; 11(8):1639-42. PubMed ID: 12659749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ezetimibe anhydrate, determined from laboratory powder diffraction data.
    Brüning J; Alig E; Schmidt MU
    Acta Crystallogr C; 2010 Jul; 66(Pt 7):o341-4. PubMed ID: 20603561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ezetimibe improves high fat and cholesterol diet-induced non-alcoholic fatty liver disease in mice.
    Zheng S; Hoos L; Cook J; Tetzloff G; Davis H; van Heek M; Hwa JJ
    Eur J Pharmacol; 2008 Apr; 584(1):118-24. PubMed ID: 18329014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ezetimibe (Schering-Plough).
    Meng CQ
    Curr Opin Investig Drugs; 2001 Mar; 2(3):389-92. PubMed ID: 11575710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ezetimibe. Schering-Plough.
    Meng CQ
    Curr Opin Investig Drugs; 2002 Mar; 3(3):427-32. PubMed ID: 12054091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [New treatment option for decreasing blood cholesterol level--clinical significance of inhibition of both, cholesterol absorption and synthesis].
    Paragh G; Márk L; Czine Z
    Orv Hetil; 2004 Apr; 145(15):805-11. PubMed ID: 15188635
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo responsiveness to ezetimibe correlates with niemann-pick C1 like-1 (NPC1L1) binding affinity: Comparison of multiple species NPC1L1 orthologs.
    Hawes BE; O'neill KA; Yao X; Crona JH; Davis HR; Graziano MP; Altmann SW
    Mol Pharmacol; 2007 Jan; 71(1):19-29. PubMed ID: 17005902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Ezetimibe--intestinal cholesterol absorbtion inhibitor].
    Pikto-Pietkiewicz W; Pasierski T
    Kardiol Pol; 2006 Dec; 64(12):1434-41. PubMed ID: 17206545
    [No Abstract]   [Full Text] [Related]  

  • 36. The pharmacologic elegance of inhibiting cholesterol absorption and synthesis while providing a homeostatic balance.
    Catapano AL
    Fundam Clin Pharmacol; 2007 Nov; 21 Suppl 2():21-6. PubMed ID: 18001316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Total synthesis of ezetimibe, a cholesterol absorption inhibitor.
    Śnieżek M; Stecko S; Panfil I; Furman B; Chmielewski M
    J Org Chem; 2013 Jul; 78(14):7048-57. PubMed ID: 23763523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple mechanisms of hypocholesterolemic action of pactimibe, a novel acyl-coenzyme A:cholesterol acyltransferase inhibitor.
    Kitayama K; Koga T; Inaba T; Fujioka T
    Eur J Pharmacol; 2006 Aug; 543(1-3):123-32. PubMed ID: 16814766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypocholesterolemic activity of some novel azetidin-2-ones in diet and diabetes induced hypercholesterolemia in rats.
    Goel RK; Thind JS; Bal CS; Mahajan MP; Kulkarni SK
    Pharmazie; 2005 May; 60(5):369-74. PubMed ID: 15918588
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.